Clinical Trial Update: Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing rituximab for efficacy and safety in first episode pediatric steroid-sensitive nephrotic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-sensitive Nephrotic Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Steroid-Sensitive Nephrotic Syndrome | Phase 2 | Status: COMPLETED